317 related articles for article (PubMed ID: 31582045)
21. Physiologic MRI for assessment of response to therapy and prognosis in glioblastoma.
Shiroishi MS; Boxerman JL; Pope WB
Neuro Oncol; 2016 Apr; 18(4):467-78. PubMed ID: 26364321
[TBL] [Abstract][Full Text] [Related]
22. MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients.
Brandes AA; Franceschi E; Tosoni A; Blatt V; Pession A; Tallini G; Bertorelle R; Bartolini S; Calbucci F; Andreoli A; Frezza G; Leonardi M; Spagnolli F; Ermani M
J Clin Oncol; 2008 May; 26(13):2192-7. PubMed ID: 18445844
[TBL] [Abstract][Full Text] [Related]
23. Utility of Magnetic Resonance Perfusion Imaging in Quantifying Active Tumor Fraction and Radiation Necrosis in Recurrent Intracranial Tumors.
Shah AH; Kuchakulla M; Ibrahim GM; Dadheech E; Komotar RJ; Gultekin SH; Ivan ME
World Neurosurg; 2019 Jan; 121():e836-e842. PubMed ID: 30312826
[TBL] [Abstract][Full Text] [Related]
24. Neuroimaging of Brain Tumors: Pseudoprogression, Pseudoresponse, and Delayed Effects of Chemotherapy and Radiation.
Dietrich J; Winter SF; Klein JP
Semin Neurol; 2017 Oct; 37(5):589-596. PubMed ID: 29207418
[No Abstract] [Full Text] [Related]
25. [Autopsy cases of glioblastoma multiforme: treatment results of high-dose fractionated radiation therapy and CT scan findings].
Tamura M; Ohye C; Hayakawa K; Niibe H; Ishida Y
Gan No Rinsho; 1989 Sep; 35(11):1339-46. PubMed ID: 2554007
[TBL] [Abstract][Full Text] [Related]
26. The Role of Apparent Diffusion Coefficient Values in Glioblastoma: Differentiating Tumor Progression Versus Treatment-Related Changes.
Kamali A; Gandhi A; Nunez LC; Lugo AE; Arevalo-Espejo O; Zhu JJ; Esquenazi-Levy Y; Zhang X; Riascos RF
J Comput Assist Tomogr; 2022 Nov-Dec 01; 46(6):923-928. PubMed ID: 36112011
[TBL] [Abstract][Full Text] [Related]
27. Correlation of Dynamic O-(2-[
Lohmann P; Piroth MD; Sellhaus B; Weis J; Geisler S; Oros-Peusquens AM; Mohlberg H; Amunts K; Shah NJ; Galldiks N; Langen KJ
World Neurosurg; 2018 Nov; 119():e653-e660. PubMed ID: 30077752
[TBL] [Abstract][Full Text] [Related]
28. Dynamic contrast enhanced T1 MRI perfusion differentiates pseudoprogression from recurrent glioblastoma.
Thomas AA; Arevalo-Perez J; Kaley T; Lyo J; Peck KK; Shi W; Zhang Z; Young RJ
J Neurooncol; 2015 Oct; 125(1):183-90. PubMed ID: 26275367
[TBL] [Abstract][Full Text] [Related]
29. Post-treatment imaging changes in primary brain tumors.
O'Brien BJ; Colen RR
Curr Oncol Rep; 2014; 16(8):397. PubMed ID: 24997979
[TBL] [Abstract][Full Text] [Related]
30. Advanced Imaging Techniques for Differentiating Pseudoprogression and Tumor Recurrence After Immunotherapy for Glioblastoma.
Li Y; Ma Y; Wu Z; Xie R; Zeng F; Cai H; Lui S; Song B; Chen L; Wu M
Front Immunol; 2021; 12():790674. PubMed ID: 34899760
[TBL] [Abstract][Full Text] [Related]
31. Pseudoprogression versus true progression in glioblastoma patients: A multiapproach literature review: Part 1 - Molecular, morphological and clinical features.
Le Fèvre C; Lhermitte B; Ahle G; Chambrelant I; Cebula H; Antoni D; Keller A; Schott R; Thiery A; Constans JM; Noël G
Crit Rev Oncol Hematol; 2021 Jan; 157():103188. PubMed ID: 33307200
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of pseudoprogression rates and tumor progression patterns in a phase III trial of bevacizumab plus radiotherapy/temozolomide for newly diagnosed glioblastoma.
Wick W; Chinot OL; Bendszus M; Mason W; Henriksson R; Saran F; Nishikawa R; Revil C; Kerloeguen Y; Cloughesy T
Neuro Oncol; 2016 Oct; 18(10):1434-41. PubMed ID: 27515827
[TBL] [Abstract][Full Text] [Related]
33. Glioblastoma multiforme imaging: the role of nuclear medicine.
Alexiou GA; Tsiouris S; Voulgaris S; Kyritsis AP; Fotopoulos AD
Curr Radiopharm; 2012 Oct; 5(4):308-13. PubMed ID: 22642425
[TBL] [Abstract][Full Text] [Related]
34. Radiation necrosis following treatment of high grade glioma--a review of the literature and current understanding.
Siu A; Wind JJ; Iorgulescu JB; Chan TA; Yamada Y; Sherman JH
Acta Neurochir (Wien); 2012 Feb; 154(2):191-201; discussion 201. PubMed ID: 22130634
[TBL] [Abstract][Full Text] [Related]
35. Utilizing 18F-fluoroethyltyrosine (FET) positron emission tomography (PET) to define suspected nonenhancing tumor for radiation therapy planning of glioblastoma.
Hayes AR; Jayamanne D; Hsiao E; Schembri GP; Bailey DL; Roach PJ; Khasraw M; Newey A; Wheeler HR; Back M
Pract Radiat Oncol; 2018; 8(4):230-238. PubMed ID: 29730279
[TBL] [Abstract][Full Text] [Related]
36. Pseudoprogression and pseudoresponse in the treatment of gliomas.
Brandsma D; van den Bent MJ
Curr Opin Neurol; 2009 Dec; 22(6):633-8. PubMed ID: 19770760
[TBL] [Abstract][Full Text] [Related]
37. Potential for differentiation of glioma recurrence from radionecrosis using integrated
Sogani SK; Jena A; Taneja S; Gambhir A; Mishra AK; D'Souza MM; Verma SM; Hazari PP; Negi P; Jadhav GK
Neurol India; 2017; 65(2):293-301. PubMed ID: 28290392
[TBL] [Abstract][Full Text] [Related]
38. Treatment-related change versus tumor recurrence in high-grade gliomas: a diagnostic conundrum--use of dynamic susceptibility contrast-enhanced (DSC) perfusion MRI.
Fatterpekar GM; Galheigo D; Narayana A; Johnson G; Knopp E
AJR Am J Roentgenol; 2012 Jan; 198(1):19-26. PubMed ID: 22194475
[TBL] [Abstract][Full Text] [Related]
39. Differentiation of tumor progression from pseudoprogression in patients with posttreatment glioblastoma using multiparametric histogram analysis.
Cha J; Kim ST; Kim HJ; Kim BJ; Kim YK; Lee JY; Jeon P; Kim KH; Kong DS; Nam DH
AJNR Am J Neuroradiol; 2014 Jul; 35(7):1309-17. PubMed ID: 24676005
[TBL] [Abstract][Full Text] [Related]
40. Differentiation of true progression from pseudoprogression in glioblastoma treated with radiation therapy and concomitant temozolomide: comparison study of standard and high-b-value diffusion-weighted imaging.
Chu HH; Choi SH; Ryoo I; Kim SC; Yeom JA; Shin H; Jung SC; Lee AL; Yoon TJ; Kim TM; Lee SH; Park CK; Kim JH; Sohn CH; Park SH; Kim IH
Radiology; 2013 Dec; 269(3):831-40. PubMed ID: 23771912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
